| TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma | |
| Xiao, Wenjing; Du, Nan; Huang, Taoyuan; Guo, Jinan; Mo, Xingkui; Yuan, Tao; Chen, Yong; Ye, Ting; Xu, Chunwei; Wang, Wenxian | |
| 刊名 | EBIOMEDICINE
 |
| 2018 | |
| 卷号 | 32 |
| 关键词 | Anti-CTLA-4 TP53 Melanoma Biomarker Tumor mutational |
| ISSN号 | 2352-3964 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3605189 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Xiao, Wenjing,Du, Nan,Huang, Taoyuan,et al. TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma[J]. EBIOMEDICINE,2018,32. |
| APA | Xiao, Wenjing.,Du, Nan.,Huang, Taoyuan.,Guo, Jinan.,Mo, Xingkui.,...&Chen, Jing.(2018).TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma.EBIOMEDICINE,32. |
| MLA | Xiao, Wenjing,et al."TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma".EBIOMEDICINE 32(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论